Screening for prostate cancer: Recommendation and rationale

被引:146
作者
Berg, AO [1 ]
Allan, JD
Frame, P
Homer, CJ
Johnson, MS
Klein, JD
Lieu, TA
Mulrow, CD
Orleans, CT
Peipert, JF
Pender, NJ
Siu, AL
Teutsch, SM
Westhoff, C
Woolf, SH
机构
[1] Univ Washington, Seattle, WA 98195 USA
[2] Univ Maryland, Sch Nursing, Baltimore, MD 21201 USA
[3] Univ Rochester, Sch Med, Rochester, NY 14627 USA
[4] Natl Initiat Childrens Healthcare Qual, Boston, MA USA
[5] Univ Med & Dent New Jersey, New Jersey Med Sch, Newark, NJ 07103 USA
[6] Harvard Univ Pilgrim Hlth Care, Boston, MA 02115 USA
[7] Harvard Univ, Sch Med, Boston, MA 02115 USA
[8] Univ Texas, Hlth Sci Ctr, San Antonio, TX 78284 USA
[9] Robert Wood Johnson Fdn, Princeton, NJ 08540 USA
[10] Women & Infants Hosp Rhode Isl, Providence, RI 02908 USA
[11] Univ Michigan, Ann Arbor, MI 48109 USA
[12] CUNY Mt Sinai Sch Med, New York, NY 10029 USA
[13] Merck & Co Inc, West Point, PA USA
[14] Columbia Univ, New York, NY 10032 USA
[15] Virginia Commonwealth Univ, Fairfax, VA USA
关键词
D O I
10.7326/0003-4819-137-11-200212030-00013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This statement summarizes the current U.S. Preventive Services Task Force (USPSTF) recommendations on screening for prostate cancer and updates the 1996 recommendations on this topic. The complete USPSTF recommendation and rationale statement on this topic, which includes a brief review of the supporting evidence, is available through the USPSTF Web site (www.preventiveservices.ahrq.gov), the National Guideline Clearinghouse (www.guideline.gov), and in print through the Agency for Healthcare Research and Quality Publications Clearinghouse (telephone, 800-358- 9295; e-mail, ahrqpubs@ahrq.gov). The complete information on which this statement is based, including tables and references, is available in the accompanying article in this issue and in the summary of the evidence and systematic evidence review on the Web sites already mentioned.
引用
收藏
页码:915 / 916
页数:2
相关论文
共 8 条